Decoy Therapeutics Inc. Other Current Assets
Decoy Therapeutics Inc. (DCOY) had Other Current Assets of $146.07 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Other Assets, Current $146.07K.
- 2026-03-31: Other Assets, Current $305.75K.
- 2025-12-31: Other Assets, Current $275.22K.
- 2025-09-30: Other Assets, Current $80.95K.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $146.07K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $305.75K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $275.22K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $80.95K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $26.45K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $61.63K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $43.67K 10-K · filed 2026-03-31 |
| 2024-09-30 | $119.02K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $151.57K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $178.07K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $151.27K 10-K · filed 2025-03-21 |
| 2023-09-30 | $83.12K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $174.40K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $156.51K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $167.58K 10-K · filed 2024-03-22 |
| 2022-09-30 | $248.65K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $215.64K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $195.38K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $172.99K 10-K · filed 2023-03-27 |
| 2021-09-30 | $95.23K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $141.55K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $206.49K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $137.78K 10-K · filed 2022-03-25 |
| 2020-09-30 | $139.91K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $119.49K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $144.79K 10-Q/A · filed 2020-05-15 |
| 2019-12-31 | $136.06K 10-K · filed 2021-03-18 |
| 2019-09-30 | $118.97K 10-Q · filed 2019-11-12 |
| 2018-12-31 | $22.27K 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |